PDUFA Date of October 9th for Mylan's (MYL) Biologics License Application for Biosimilar to Amgen's (AMGN) Neulasta

Source Link:

http://www.prnewswire.com/news-releases/us-fda-accepts-biologics-license-application-bla-for-mylan-and-biocons-proposed-biosimilar-pegfilgrastim-for-review-300408246.html